The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH

Critical Care Clinical Trial

— BIATICH  

Official title:

The Effect of BIA Monitoring of Brainedemaontheneurological Prognosis of Supratentorial Massive Intracerebral Hemorrhage - A Randomized, Contrast，Multi-center Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05593380
• Other study ID #: sjnkzhangle
• Secondary ID: 2018FY100900
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 15, 2022
• Est. completion date: January 31, 2024

Study information

• Verified date: September 2022
• Source: Xiangya Hospital of Central South University
• Contact: Zhang Le, PhD
• Phone: 13973187150
• Email: zlzdzlzd[@]csu.edu.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Spontaneous cerebral hemorrhage (SICH) is a hemorrhage caused by the rupture of a blood vessel within the brain parenchyma that is non-traumatic. Its rapid onset and dangerous condition seriously threaten human health; it accounts for about 15% of strokes and 50% of stroke-related mortality. Hunan Province is recognized as one of the high incidence areas of cerebral hemorrhage in the world; according to statistics, the direct economic loss caused by cerebral hemorrhage in Hunan Province is more than 1 billion yuan per year, which should be paid great attention. A 30-day follow-up study of large-volume cerebral hemorrhage (defined as supratentorial hemorrhage greater than 30 ml, infratentorial greater than 5 ml, and thalamus and cerebellum greater than 15 ml) found that the morbidity and mortality rate of ICH with hemorrhage of 30-60 ml was as high as 44-74%, while the morbidity and mortality rate of ICH with hemorrhage of <30 ml was 19% and that of >60 ml was 91%. According to studies, the occurrence of hematoma occupancy and malignant cerebral edema in large-volume cerebral hemorrhage can lead to secondary malignant intracranial pressure elevation and subsequent secondary brain injury, which are the main factors of high morbidity and mortality and poor prognosis in patients with large-volume cerebral hemorrhage. Clinical monitoring and management is the key to treatment, and despite aggressive surgical treatment and anti-brain edema therapy, a large number of patients progress to malignant brain edema disease, leading to poor outcomes. Therefore, this project intends to conduct a multicenter clinical trial of non-invasive monitoring of large volume cerebral hemorrhage on the curtain in the Hunan region to explore the impact of non-invasive brain edema monitoring management based on bioelectrical impedance technology on patient prognosis; and to explore early biomarkers of malignant brain edema through metabolomic analysis and the mechanism of malignant brain edema occurrence through multi-omic analysis to provide data support for the clinical treatment application of malignant brain edema.

Description:

Intracranial pressure and cerebral edema monitoring are commonly used neurological monitoring modalities in neurocritical conditions worldwide. There remains uncertainty in the prognosis of neurological function in patients with traumatic and non-traumatic brain injury with invasive intracranial pressure monitoring, non-invasive intracranial pressure monitoring and cerebral edema monitoring modalities, and differences in clinical practice between the two tests in patients with large volume cerebral hemorrhage. The objectives of this study were to explore the differences between non-invasive brain edema monitoring based on BIA technology (Chongqing Born-Fruk Medical Equipment Co., Ltd., Chongqing, China) and invasive intracranial pressure monitoring, and whether non-invasive brain edema monitoring based on BIA technology is more beneficial for the long-term prognosis of patients with episodic large-volume cerebral hemorrhage, whether there are fewer complications, and whether such monitoring measures are more acceptable in clinical practice. The trial is a prospective, randomized, open-label, controlled, multi-clinical center trial; the sample size was calculated based on previous studies to include a total of approximately 776 cases, and is expected to include more than 20 clinical institutions with extensive experience in the treatment of large volume cerebral hemorrhage in Hunan Province, China. Patients diagnosed with supratentorial parenchymal cerebral hemorrhage (hemorrhage volume ≥ 30 ml according to the Coniglobus formula ) by CT examination within 48 hours of onset were included, and informed consent was provided to patients who met the enrollment criteria. The included cases were divided into surgical and non-surgical groups according to the guidelines for the treatment of cerebral hemorrhage and taking into account the patient's condition, the physician's decision and the family's choice of whether to receive surgical treatment (craniotomy or minimally invasive surgery) or conservative treatment, thus avoiding the ethical risk of large-volume cerebral hemorrhage. Enrolled non-surgical cases were randomly assigned 1:1 to the BIA non-invasive cerebral edema monitoring group and theImaging clinical examination（ICE) group. Cases that received surgical treatment were divided into two subgroups, the craniotomy group and the minimally invasive surgery group, depending on the type of surgery received, and of the two subgroups were randomly assigned in a 1 : 1 : 1 ratio to the invasive ICP monitoring group, the BIA technique noninvasive brain edema monitoring group, and the Imaging clinical examination（ICE） group. All the related investigative organization and individuals will obey the Declaration of Helsinki and Chinese Good Clinical Practice standard. A Data and Safety Monitoring Board (DSMB) will regularly monitor safety during the study.The trial has been approved by Institutional Review Board (IRB) and Ethics Committee(EC) in Xiangya Hospital Central South Uniersity.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 776
• Est. completion date: January 31, 2024
• Est. primary completion date: October 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Age >18 years old and Age <80 years old.

2. Diagnosed of a supratentorial spontaneous intracerebral hemorrhage.

3. Diagnosis of supratentorial large-volume cerebral hemorrhage by CT or other imaging and meeting the diagnostic criteria for large-volume cerebral hemorrhage(hemorrhage volume = 30 mL of supratentorial cerebral parenchymal hematoma volume according to the Coniglobus formula on the first CT scan at onset).

4. Admission to study hospital within 48 hours of the disease.

5. The family signed the informed consent.

Exclusion Criteria:

1. traumatic cerebral hemorrhage, cerebral amyloid angiopathy(CAA), secondary cerebral hemorrhage due to other specific etiologies (aneurysm, vascular malformation, smoker's disease, coagulopathy, aneurysmal stroke, vasculitis, cerebral venous thrombosis, hemorrhagic cerebral infarction, etc.)

2. the presence of fixed bilateral dilated pupils on admission, no recovery of pupils after initial dehydration treatment, and very poor survival

3. patients with extremely unstable vital signs after admission, with extremely poor prognosis and those considered non-viable, and patients whose families have abandoned follow-up treatment

4. patients who are pregnant or lactating.

5. patients with bilateral temporal skin ulceration, or subcutaneous hematoma in which monitoring electrode placement cannot be implemented

6. the presence of other serious underlying diseases (intractable hypoxemia and circulatory failure with cardiopulmonary insufficiency that is difficult to correct by treatment, severe abnormal coagulation, severely reduced platelets, severe hepatic and renal insufficiency, combined neurodegenerative diseases, psychiatric diseases, autoimmune diseases, malignant tumors, thyroid diseases, etc.)

7. the patient is agitated, coughing or choking too frequently, unable to be sedated or has difficulty in handling.

8. those with mRS score > 2 before this onset.

Related Conditions & MeSH terms

• Bioelectrical Impedance Analysis
• Brain Edema
• Cerebral Hemorrhage
• Critical Care
• Hemorrhage
• Hypertension
• Intracranial Hemorrhage, Hypertensive
• Intracranial Hypertension
• Monitoring
• Treatment Outcome

Intervention

Device:
• Non-invasive intracranial pressure monitoring
Treatment based on readings from Bioelectrical impedance analysis monitor(intracranial pressure and perturbation index (PI)).

Other:
• Parenchymal Intracranial pressure monitor
Treatment based on readings from Parenchymal intracranial pressure monitor.
• Treatment based on clinical and imaging observations
Treatment based on clinical and imaging observations.

Locations

Country	Name	City	State
China	Brain Hospital of Hunan Province	Changsha	Hunan
China	Changsha Eighth Hospital(Changsha Hospital of Traditional Chinese Medicine)	Changsha	Hunan
China	Changsha Fourth Hospital	Changsha	Hunan
China	Hunan Provincial People's Hospital	Changsha	Hunan
China	The Third Xiangya Hospital of Central South University	Changsha	Hunan
China	XiangYa School of Medicine	Changsha	Hunan

Sponsors (1)

Lead Sponsor	Collaborator
Xiangya Hospital of Central South University

Country where clinical trial is conducted

China, 

References & Publications (29)

Aiolfi A, Khor D, Cho J, Benjamin E, Inaba K, Demetriades D. Intracranial pressure monitoring in severe blunt head trauma: does the type of monitoring device matter? J Neurosurg. 2018 Mar;128(3):828-833. doi: 10.3171/2016.11.JNS162198. Epub 2017 May 26. — View Citation

Andrews PJ, Citerio G. Intracranial pressure. Part one: historical overview and basic concepts. Intensive Care Med. 2004 Sep;30(9):1730-3. Epub 2004 Jul 9. — View Citation

Bales JW, Bonow RH, Buckley RT, Barber J, Temkin N, Chesnut RM. Primary External Ventricular Drainage Catheter Versus Intraparenchymal ICP Monitoring: Outcome Analysis. Neurocrit Care. 2019 Aug;31(1):11-21. doi: 10.1007/s12028-019-00712-9. — View Citation

Bao YH, Liang YM, Gao GY, Pan YH, Luo QZ, Jiang JY. Bilateral decompressive craniectomy for patients with malignant diffuse brain swelling after severe traumatic brain injury: a 37-case study. J Neurotrauma. 2010 Feb;27(2):341-7. doi: 10.1089/neu.2009.104 — View Citation

Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N, Rubiano AM, Shutter L, Tasker RC, Vavilala MS, Wilberger J, Wright DW, Ghajar J. Guidelines for the Management of Severe Traumatic Brain Injury, — View Citation

Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Pridgeon J, Barber J, Machamer J, Chaddock K, Celix JM, Cherner M, Hendrix T; Global Neurotrauma Research Group. A trial of intracranial-pressure monitoring in traumatic b — View Citation

Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):813-21. Review. — View Citation

Dallagiacoma S, Robba C, Graziano F, Rebora P, Hemphill JC, Galimberti S, Citerio G; SYNAPSE-ICU Investigators. Intracranial Pressure Monitoring in Patients With Spontaneous Intracerebral Hemorrhage: Insights From the SYNAPSE-ICU Study. Neurology. 2022 Ju — View Citation

Dubourg J, Javouhey E, Geeraerts T, Messerer M, Kassai B. Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2011 Jul;37(7):1059-68. doi: 10.1007/s00134- — View Citation

Fernando SM, Tran A, Cheng W, Rochwerg B, Taljaard M, Kyeremanteng K, English SW, Sekhon MS, Griesdale DEG, Dowlatshahi D, McCredie VA, Wijdicks EFM, Almenawer SA, Inaba K, Rajajee V, Perry JJ. Diagnosis of elevated intracranial pressure in critically ill — View Citation

GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016 — View Citation

He LY, Wang J, Luo Y, Dong WW, Liu LX. Application of non-invasive cerebral electrical impedance measurement on brain edema in patients with cerebral infarction. Neurol Res. 2010 Sep;32(7):770-4. doi: 10.1179/016164109X12478302362572. Epub 2009 Sep 1. — View Citation

Helbok R, Olson DM, Le Roux PD, Vespa P; Participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring. Intracranial pressure and cerebral perfusion pressure monitoring in non-TBI patients: special considerations. Ne — View Citation

Hiler M, Czosnyka M, Hutchinson P, Balestreri M, Smielewski P, Matta B, Pickard JD. Predictive value of initial computerized tomography scan, intracranial pressure, and state of autoregulation in patients with traumatic brain injury. J Neurosurg. 2006 May — View Citation

Kumar G, Kalita J, Misra UK. Raised intracranial pressure in acute viral encephalitis. Clin Neurol Neurosurg. 2009 Jun;111(5):399-406. doi: 10.1016/j.clineuro.2009.03.004. Epub 2009 Apr 15. Review. — View Citation

LANGFITT TW, WEINSTEIN JD, KASSELL NF, SIMEONE FA. TRANSMISSION OF INCREASED INTRACRANIAL PRESSURE. I. WITHIN THE CRANIOSPINAL AXIS. J Neurosurg. 1964 Nov;21:989-97. — View Citation

Lenfeldt N, Koskinen LO, Bergenheim AT, Malm J, Eklund A. CSF pressure assessed by lumbar puncture agrees with intracranial pressure. Neurology. 2007 Jan 9;68(2):155-8. — View Citation

Liu H, Wang W, Cheng F, Yuan Q, Yang J, Hu J, Ren G. External Ventricular Drains versus Intraparenchymal Intracranial Pressure Monitors in Traumatic Brain Injury: A Prospective Observational Study. World Neurosurg. 2015 May;83(5):794-800. doi: 10.1016/j.w — View Citation

Lou JH, Wang J, Liu LX, He LY, Yang H, Dong WW. Measurement of brain edema by noninvasive cerebral electrical impedance in patients with massive hemispheric cerebral infarction. Eur Neurol. 2012;68(6):350-7. doi: 10.1159/000342030. Epub 2012 Oct 23. — View Citation

Makarenko S, Griesdale DE, Gooderham P, Sekhon MS. Multimodal neuromonitoring for traumatic brain injury: A shift towards individualized therapy. J Clin Neurosci. 2016 Apr;26:8-13. doi: 10.1016/j.jocn.2015.05.065. Epub 2016 Jan 2. Review. — View Citation

Miller C, Armonda R; Participants in the International Multi-disciplinary Consensus Conference on Multimodality Monitoring. Monitoring of cerebral blood flow and ischemia in the critically ill. Neurocrit Care. 2014 Dec;21 Suppl 2:S121-8. doi: 10.1007/s120 — View Citation

Nag DS, Sahu S, Swain A, Kant S. Intracranial pressure monitoring: Gold standard and recent innovations. World J Clin Cases. 2019 Jul 6;7(13):1535-1553. doi: 10.12998/wjcc.v7.i13.1535. Review. — View Citation

O'Sullivan MG, Statham PF, Jones PA, Miller JD, Dearden NM, Piper IR, Anderson SI, Housley A, Andrews PJ, Midgley S, et al. Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial co — View Citation

Raj R, Bendel S, Reinikainen M, Hoppu S, Laitio R, Ala-Kokko T, Curtze S, Skrifvars MB. Costs, outcome and cost-effectiveness of neurocritical care: a multi-center observational study. Crit Care. 2018 Sep 20;22(1):225. doi: 10.1186/s13054-018-2151-5. — View Citation

Reid A, Marchbanks RJ, Burge DM, Martin AM, Bateman DE, Pickard JD, Brightwell AP. The relationship between intracranial pressure and tympanic membrane displacement. Br J Audiol. 1990 Apr;24(2):123-9. — View Citation

Ropper AH. Management of raised intracranial pressure and hyperosmolar therapy. Pract Neurol. 2014 Jun;14(3):152-8. doi: 10.1136/practneurol-2014-000811. Epub 2014 Jan 30. Review. — View Citation

Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med. 1998 Jul;26(7):1265-70. — View Citation

Tavakoli S, Peitz G, Ares W, Hafeez S, Grandhi R. Complications of invasive intracranial pressure monitoring devices in neurocritical care. Neurosurg Focus. 2017 Nov;43(5):E6. doi: 10.3171/2017.8.FOCUS17450. Review. — View Citation

Treggiari MM, Schutz N, Yanez ND, Romand JA. Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review. Neurocrit Care. 2007;6(2):104-12. Review. — View Citation

* Note: There are 29 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	In a randomized controlled trial, test the effect on outcomes of management of severe supratentorial massive intracerebral hemorrhage guided by information from BIA monitors vs. ICP monitors and a standard empiric protocol.	Long-term outcome measures of neurological disability . mRS, NIHSS and Extended Glasgow Outcome Scale score.	90 days
Secondary	Neurological recovery	The difference value of the NIHSS between Day 14/Day 90 and the baseline.	90 days
Secondary	Correlation of edema quantification features	Comparison of the trend of brain edema coefficients monitored by the BIA technique with the quantitative features of 3D-Slice edema on CT images.	14 days
Secondary	Modified Rankin scale	modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after ICH,good prognosis (mRS score 0-2), generally good prognosis (mRS score 3-4) , Poor prognosis (mRS >4 points).	90 days
Secondary	Duration of ICU treatment	Time from the start of patient randomization to stable transfer out of the ICU.	90 days
Secondary	GOS-E score	The difference value of the GOS-E between Day 14/Day 90,was used to evaluate the functional outcomes after ICH.	90 days
Secondary	Quality of life score (EQ-5D)	Generic health status evaluated by EQ-5D questionnaire at the end of the therapy.	90 days
Secondary	Length of hospitalization	Length of stay of patients throughout the treatment period since randomization.	90 days
Secondary	The incidence of serious adverse events	The percentage of the Severity Adverse Events within the 14 days/90 days of the therapy.	90 days
Secondary	Total mortality	All deaths reported post-randomization will be recorded and adjudicated	90 days
Secondary	Adverse Events	The percentage of the Adverse Events during the therapy.	90 days
Secondary	Severity Adverse Event	The percentage of the Severity Adverse Events within the 14 days of the therapy.	14 days
Secondary	Total mortality	All deaths reported post-randomization will be recorded and adjudicated. Deaths will be subclassified by the adjudication committee as cardiovascular or non-cardiovascular.	14 days
Secondary	Adverse Events	The percentage of the Adverse Events during the therapy.	14 days
Secondary	The incidence of adverse events That are related to treatment	Incidence of complications that occurred during the use of invasive ICP or noninvasive cerebral edema monitoring after patient randomization. such as intracranial infection, probe displacement, recurrent intracranial hemorrhage, skin infection, etc.	90 days

External Links

•   A new method of noninvasive brain-edema monitoring in patients with intracranial tumor: cerebral electrical impedance measurement
•   An applied research on non-invasive and dynamic monitor of cerebral edema in patients after craniotomy
•   An applied research on non-invasive and dynamic monitor of cerebral edema in patients after craniotomy
•   Application of continuous intracranial pressure monitoring in hypertensive cerebral hemorrhge
•   Application of noninvasive cerebral electrical impedance measurement on brain edema in patients with intracerebral hemorrhage
•   Chinese Expert Consensus on Monitoring and Treatment of Spontaneous Large Volume Cerebral Hemorrhage
•   Disturbance method of electric current field and its application in impedance imaging
•   Noninvasive monitoring of hypertensive intracerebral hemorrhage and perihematomal tissue edema
•   Trunk subdivision bioelectrical impedance analysis of body composition